Home / Drug shortages / Midazolam Hydrochloride Injection

Midazolam Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 04/02/2020. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-411-12
Dosage Form
Injection
Presentation
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)
Initial Posting
04/02/2020
Revised Date

Reason

Demand increase for the drug

FDA data resources